Cargando…
Randomized Implementation of a Primary Human Papillomavirus Testing–based Cervical Cancer Screening Protocol for Women 34 to 69 Years in Norway
BACKGROUND: Cervical cancer screening programs are facing a programmatic shift where screening protocol based on human papillomavirus testing (HPV-Screening protocol) is replacing the liquid-based cytology (LBC-Screening protocol). For safe technology transfer within the nationwide screening program...
Autores principales: | Nygård, Mari, Engesæter, Birgit, Castle, Philip E., Berland, Jannicke Mohr, Eide, Maj Liv, Iversen, Ole Erik, Jonassen, Christine Monceyron, Christiansen, Irene Kraus, Vintermyr, Olav Karsten, Tropé, Ameli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9437559/ https://www.ncbi.nlm.nih.gov/pubmed/35793700 http://dx.doi.org/10.1158/1055-9965.EPI-22-0340 |
Ejemplares similares
-
Quality assurance of human papillomavirus (HPV) testing in the implementation of HPV primary screening in Norway: an inter-laboratory reproducibility study
por: Engesæter, Birgit, et al.
Publicado: (2016) -
HPV self-sampling among long-term non-attenders to cervical cancer screening in Norway: a pragmatic randomised controlled trial
por: Aasbø, Gunvor, et al.
Publicado: (2022) -
Substantial Decline in Prevalence of Vaccine-Type and Nonvaccine-Type Human Papillomavirus (HPV) in Vaccinated and Unvaccinated Girls 5 Years After Implementing HPV Vaccine in Norway
por: Feiring, Berit, et al.
Publicado: (2018) -
Real-world data on cervical cancer risk stratification by cytology and HPV genotype to inform the management of HPV-positive women in routine cervical screening
por: Hashim, Dana, et al.
Publicado: (2020) -
Clinical performance of Anyplex II HPV28 by human papillomavirus type and viral load in a referral population
por: Baasland, Ingrid, et al.
Publicado: (2019)